{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:53Z","timestamp":1786997933733,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011798","name":"Ministry of Agriculture and Rural Affairs of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.08.053","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:42:07Z","timestamp":1600324927000},"page":"6872-6881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of capsid in the flaviviral life cycle and perspectives for vaccine development"],"prefix":"10.1016","volume":"38","author":[{"given":"Yu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-353X","authenticated-orcid":false,"given":"Anchun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.053_b0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.08.053_b0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2020.08.053_b0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nsb990","article-title":"Visualization of membrane protein domains by cryo-electron microscopy of dengue virus","volume":"10","author":"Zhang","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0020","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1128\/JVI.00037-07","article-title":"Structure of immature West Nile virus","volume":"81","author":"Zhang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0025","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.08.053_b0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 angstrom resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.08.053_b0035","unstructured":"Knipe D, Howley P, Griffin D, Lamb R, Martin M, Roizman B, et al. Fields Virology, vol. 1 & 2. Lippincott Williams & Wilkins; 2001."},{"key":"10.1016\/j.vaccine.2020.08.053_b0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/viro.1997.8608","article-title":"A conserved internal hydrophobic domain mediates the stable membrane integration of the dengue virus capsid protein","volume":"233","author":"Markoff","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/JVI.77.1.443-451.2003","article-title":"Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C","volume":"77","author":"Kofler","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0050","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.08.053_b0055","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1021\/acs.biochem.9b00194","article-title":"Dynamics of zika virus capsid protein in solution: the properties and exposure of the hydrophobic cleft are controlled by the alpha-helix 1 sequence","volume":"58","author":"Morando","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2020.08.053_b0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.str.2004.04.024","article-title":"West Nile virus core protein; tetramer structure and ribbon formation","volume":"12","author":"Dokland","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2020.08.053_b0065","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jmb.2018.02.006","article-title":"Crystal structure of the capsid protein from Zika virus","volume":"430","author":"Shang","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/v11070623","article-title":"Crystal structure of the Japanese encephalitis virus capsid protein","volume":"11","author":"Poonsiri","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.08.053_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41422-018-0007-9","article-title":"Structural insight into the Zika virus capsid encapsulating the viral genome","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2020.08.053_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000632","article-title":"Dengue virus capsid protein usurps lipid droplets for viral particle formation","volume":"5","author":"Samsa","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.08.053_b0085","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1128\/JVI.00940-14","article-title":"Maintenance of dimer conformation by the dengue virus core protein alpha 4-alpha 4'= helix pair is critical for nucleocapsid formation and virus production","volume":"88","author":"Teoh","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0090","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1021\/acschembio.8b00231","article-title":"Partial intrinsic disorder governs the dengue capsid protein conformational ensemble","volume":"13","author":"Boon","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/vim.2004.17.461","article-title":"Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers","volume":"17","author":"Mandl","year":"2004","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0100","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/JVI.76.7.3534-3543.2002","article-title":"Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence","volume":"76","author":"Kofler","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0105","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.08.053_b0110","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/JVI.02120-06","article-title":"Functional requirements of the yellow fever virus capsid protein","volume":"81","author":"Patkar","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0115","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.02653-08","article-title":"Helices alpha 2 and alpha 3 of west Nile virus capsid protein are dispensable for assembly of infectious virions","volume":"83","author":"Schlick","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0120","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/jvi.68.6.3794-3802.1994","article-title":"NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies","volume":"68","author":"Amberg","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0125","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","article-title":"Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM","volume":"72","author":"Stocks","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0130","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JVI.74.1.24-32.2000","article-title":"Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production","volume":"74","author":"Lee","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.02.008","article-title":"A flavivirus signal peptide balances the catalytic activity of two proteases and thereby facilitates virus morphogenesis","volume":"401","author":"Lobigs","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01174-18","article-title":"Role of capsid anchor in the morphogenesis of Zika virus","volume":"92","author":"Rana","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0155","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1099\/vir.0.064121-0","article-title":"Increased expression of capsid protein in trans enhances production of single-round infectious particles by West Nile virus DNA vaccine candidate","volume":"95","author":"Roby","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2006.04.003","article-title":"Production and characterization of vaccines based on flaviviruses defective in replication","volume":"351","author":"Mason","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.chom.2018.09.008","article-title":"A single-dose live-attenuated Zika virus vaccine with controlled infection rounds that protects against vertical transmission","volume":"24","author":"Xie","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.08.053_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/v12010027","article-title":"DENV2 Pseudoviral Particles with Unprocessed Capsid Protein Are Assembled and Infectious","volume":"12","author":"Rana","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.08.053_b0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17636","article-title":"Viral RNA switch mediates the dynamic control of flavivirus replicase recruitment by genome cyclization","volume":"5","author":"Liu","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2020.08.053_b0180","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.79.11.6631-6643.2005","article-title":"Long-range RNA-RNA interactions circularize the dengue virus genome","volume":"79","author":"Alvarez","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0185","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"Khromykh","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0190","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/JVI.02037-10","article-title":"The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication","volume":"85","author":"Friebe","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0195","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/JVI.80.5.2170-2182.2006","article-title":"RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication","volume":"80","author":"Clyde","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.virol.2008.06.034","article-title":"The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis","volume":"379","author":"Clyde","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0205","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1128\/JVI.00243-13","article-title":"Novel cis-Acting element within the capsid-coding region enhances flavivirus viral-RNA replication by regulating genome cyclization","volume":"87","author":"Liu","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0210","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/JVI.02677-14","article-title":"Overlapping local and long-range RNA-RNA interactions modulate dengue virus genome cyclization and replication","volume":"89","author":"de Borba","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.virol.2011.10.025","article-title":"Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication","volume":"422","author":"Friebe","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0220","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1099\/0022-1317-83-12-3093","article-title":"Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus","volume":"83","author":"Wang","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0225","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1128\/JVI.79.6.3448-3458.2005","article-title":"Nuclear localization of Japanese encephalitis virus core protein enhances viral replication","volume":"79","author":"Mori","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2009.08.108","article-title":"Specific interaction of capsid protein and importin-alpha\/beta influences West Nile virus production","volume":"389","author":"Bhuvanakantham","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2020.08.053_b0235","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1099\/0022-1317-70-6-1409","article-title":"Detection of dengue 4 virus core protein in the nucleus. I. A monoclonal antibody to dengue 4 virus reacts with the antigen in the nucleus and cytoplasm","volume":"70","author":"Tadano","year":"1989","journal-title":"J Gen Virol"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2020.08.053_b0240","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1099\/0022-1317-73-11-2999","article-title":"Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies","volume":"73","author":"Bulich","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0245","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1099\/vir.0.83264-0","article-title":"Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection","volume":"89","author":"Sangiambut","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1348-0421.2006.tb03789.x","article-title":"Nucleolar protein B23 interacts with Japanese encephalitis virus core protein and participates in viral replication","volume":"50","author":"Tsuda","year":"2006","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0255","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00612-19","article-title":"Functional correlation between subcellular localizations of Japanese encephalitis virus capsid protein and virus production","volume":"93","author":"Ishida","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20112219","article-title":"The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif","volume":"444","author":"Martins","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2020.08.053_b0265","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1128\/JVI.78.15.8078-8084.2004","article-title":"Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles","volume":"78","author":"Kiermayr","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-A resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0275","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature Zika virus at 9 A resolution","volume":"24","author":"Prasad","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0280","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1809304115","article-title":"Flaviviruses have imperfect icosahedral symmetry","volume":"115","author":"Therkelsen","year":"2018","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.08.053_b0285","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF01718326","article-title":"RNA binding properties of core protein of the flavivirus Kunjin","volume":"141","author":"Khromykh","year":"1996","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0290","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JVI.05431-11","article-title":"Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation","volume":"86","author":"Samsa","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0295","doi-asserted-by":"crossref","unstructured":"Boon PL, Martins AS, Enguita FJ, Lim X, Santos NC, Matsudaira PT, et al. Genome-wide Associations of Flavivirus Capsid Proteins. bioRxiv; 2019. p. 606905.","DOI":"10.1101\/606905"},{"key":"10.1016\/j.vaccine.2020.08.053_b0300","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00705-009-0350-8","article-title":"In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus","volume":"154","author":"L\u00f3pez","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0305","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.08.053_b0310","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1128\/JVI.00197-13","article-title":"Immature and mature dengue serotype 1 virus structures provide insight into the maturation process","volume":"87","author":"Kostyuchenko","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0315","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chom.2019.09.015","article-title":"Dengue NS2A protein orchestrates virus assembly","volume":"26","author":"Xie","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.08.053_b0320","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0325","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1128\/JVI.77.21.11357-11366.2003","article-title":"Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus","volume":"77","author":"Allison","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0330","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1097-2765(01)00206-4","article-title":"Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus","volume":"7","author":"Ferlenghi","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.vaccine.2020.08.053_b0335","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/0264-410X(95)00133-L","article-title":"Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis","volume":"13","author":"Heinz","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.1999.0172","article-title":"Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system","volume":"269","author":"Corver","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0345","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00804-16","article-title":"Dengue virus genome uncoating requires ubiquitination","volume":"7","author":"Byk","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2020.08.053_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.42","article-title":"Zika virus outbreak: 'a perfect storm'","volume":"5","author":"Ai","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.08.053_b0355","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2014.01.040","article-title":"A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available","volume":"32","author":"Ishikawa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0360","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX\u00ae","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0365","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Current Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.053_b0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coviro.2017.04.002","article-title":"Recent advances in human flavivirus vaccines","volume":"23","author":"Scherwitzl","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0375","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virusres.2007.03.004","article-title":"Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone","volume":"126","author":"Zhu","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.08.053_b0380","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1016\/j.vaccine.2010.06.045","article-title":"Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations","volume":"28","author":"Schlick","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0385","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/S0074-02762000000700037","article-title":"The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines","volume":"95","author":"Bonaldo","year":"2000","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2020.08.053_b0390","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/JVI.01063-09","article-title":"A trans-Complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination","volume":"84","author":"Taucher","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0395","series-title":"Replicating vaccines","first-page":"299","article-title":"Nucleic acid-based infectious and pseudo-infectious flavivirus vaccines","author":"Roby","year":"2011"},{"key":"10.1016\/j.vaccine.2020.08.053_b0400","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2006.07.038","article-title":"Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives","volume":"356","author":"Seregin","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0410","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.78.21.11605-11614.2004","article-title":"trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors","volume":"78","author":"Scholle","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0415","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2005.03.004","article-title":"Packaging the replicon RNA of the Far-Eastern subtype of tick-borne encephalitis virus into single-round infectious particles: development of a heterologous gene delivery system","volume":"23","author":"Yoshii","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0425","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"Widman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0430","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1128\/JVI.01112-07","article-title":"Production of pseudoinfectious yellow fever virus with a two-component genome","volume":"81","author":"Shustov","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0435","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.vaccine.2014.03.091","article-title":"Highly efficient production of a dengue pseudoinfectious virus","volume":"32","author":"Pang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0440","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/jgv.0.001345","article-title":"Enhanced production of infectious particles by adaptive modulation of C\u2013prM processing and C-C interaction during propagation of dengue pseudoinfectious virus in stable CprME-expressing cells","volume":"101","author":"Sangiambut","year":"2020","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0445","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.vaccine.2009.07.016","article-title":"RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters","volume":"27","author":"Widman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0450","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1016\/j.vaccine.2011.05.032","article-title":"Characterization of the RepliVax platform for replication-defective flavivirus vaccines","volume":"29","author":"Rumyantsev","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0455","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.4049\/jimmunol.1002799","article-title":"Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis","volume":"186","author":"Uhrlaub","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0460","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vaccine.2010.10.069","article-title":"Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine","volume":"29","author":"Nelson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0465","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2008.03.010","article-title":"Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis","volume":"26","author":"Ishikawa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.053_b0470","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.01891-08","article-title":"Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2","volume":"83","author":"Suzuki","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0475","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.12.015","article-title":"Efficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2\/yellow fever viruses","volume":"400","author":"Shustov","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.08.053_b0480","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1073\/pnas.1306245110","article-title":"Single-dose vaccine against tick-borne encephalitis","volume":"110","author":"Rumyantsev","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.08.053_b0485","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2020.08.053_b0490","first-page":"179","article-title":"Self-amplifying mRNA vaccines","volume":"vol. 89","author":"Brito","year":"2015"},{"key":"10.1016\/j.vaccine.2020.08.053_b0495","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discovery"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:23Z","timestamp":1759402043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2031094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":99,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X2031094X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of capsid in the flaviviral life cycle and perspectives for vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}